Simvastatin Inhibits Wnt/β-Catenin Pathway in Uterine Leiomyoma
Simvastatin Inhibits Wnt/β-Catenin Pathway in Uterine Leiomyoma
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
The Wnt/β-catenin pathway is upregulated in uterine leiomyomas, the most common benign tumors in the female reproductive tract. Simvastatin is an antihyperlipidemic drug, and previous in vitro and in vivo reports showed that it may have therapeutic effects in treating leiomyomas. The objective of this study was to examine the effects of simvastatin...
Alternative Titles
Full title
Simvastatin Inhibits Wnt/β-Catenin Pathway in Uterine Leiomyoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8557633
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8557633
Other Identifiers
ISSN
0013-7227
E-ISSN
1945-7170
DOI
10.1210/endocr/bqab211
